Page last updated: 2024-11-02

pentoxifylline and Insulinoma

pentoxifylline has been researched along with Insulinoma in 1 studies

Insulinoma: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.

Research Excerpts

ExcerptRelevanceReference
" Its high solubility and rapid metabolism results in poor bioavailability and short half-life, limiting its clinical utility."1.51Self-assembling lisofylline-fatty acid conjugate for effective treatment of diabetes mellitus. ( Chitkara, D; Italiya, KS; Mahato, RI; Mazumdar, S; Mittal, A; Sharma, S, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Italiya, KS1
Mazumdar, S1
Sharma, S1
Chitkara, D1
Mahato, RI1
Mittal, A1

Other Studies

1 other study available for pentoxifylline and Insulinoma

ArticleYear
Self-assembling lisofylline-fatty acid conjugate for effective treatment of diabetes mellitus.
    Nanomedicine : nanotechnology, biology, and medicine, 2019, Volume: 15, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Diabetes Mellitus, Experimental; Inflam

2019